ArticleJournal of Zhejiang University. Science. B2021
3D brain glioma segmentation in MRI through integrating multiple densely connected 2D convolutional neural networks.
Article in Journal of Zhejiang University. Science. B, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Embedding of ripening topology into one-stage detection for tomato cluster phenotyping.Journal of Zhejiang University. Science. B · 2026Article
- DSIT UNet a dual stream iterative transformer based UNet architecture for segmenting brain tumors from FLAIR MRI images.Scientific reports · 2025Article
- Application research on YOLOv5 model based on Lightweight Atrous Attention Module in brain tumor MRI image segmentation.Frontiers in medicine · 2025Article
- Exploring the Impact of 3D Fast Spin Echo and Inversion Recovery Gradient Echo Sequences Magnetic Resonance Imaging Acquisition on Automated Brain Tumor Segmentation.Mayo Clinic proceedings. Digital health · 2024Article
- Development and accuracy of artificial intelligence-generated prediction of facial changes in orthodontic treatment: a scoping review.Journal of Zhejiang University. Science. B · 2023Article
- Automated Classification of Intramedullary Spinal Cord Tumors and Inflammatory Demyelinating Lesions Using Deep Learning.Radiology. Artificial intelligence · 2022Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To overcome the computational burden of processing three-dimensional (3D) medical scans and the lack of spatial information in two-dimensional (2D) medical scans, a novel segmentation method was proposed that integrates the segmentation results of three densely connected 2D convolutional neural networks (2D-CNNs). In order to combine the low-level features and high-level features, we added densely connected blocks in the network structure design so that the low-level features will not be missed as the network layer increases during the learning process. Further, in order to resolve the problems of the blurred boundary of the glioma edema area, we superimposed and fused the T2-weighted fluid-attenuated inversion recovery (FLAIR) modal image and the T2-weighted (T2) modal image to enhance the edema section. For the loss function of network training, we improved the cross-entropy loss function to effectively avoid network over-fitting. On the Multimodal Brain Tumor Image Segmentation Challenge (BraTS) datasets, our method achieves dice similarity coefficient values of 0.84, 0.82, and 0.83 on the BraTS2018 training; 0.82, 0.85, and 0.83 on the BraTS2018 validation; and 0.81, 0.78, and 0.83 on the BraTS2013 testing in terms of whole tumors, tumor cores, and enhancing cores, respectively. Experimental results showed that the proposed method achieved promising accuracy and fast processing, demonstrating good potential for clinical medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.